Welcome to LookChem.com Sign In|Join Free

CAS

  • or

148528-89-6

Post Buying Request

148528-89-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

148528-89-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 148528-89-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,8,5,2 and 8 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 148528-89:
(8*1)+(7*4)+(6*8)+(5*5)+(4*2)+(3*8)+(2*8)+(1*9)=166
166 % 10 = 6
So 148528-89-6 is a valid CAS Registry Number.

148528-89-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name Boc-Abu-NH2

1.2 Other means of identification

Product number -
Other names tert-butyl [(1S)-1-carbamoylpropyl]carbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:148528-89-6 SDS

148528-89-6Relevant articles and documents

KV3 MODULATORS

-

Page/Page column 51; 63-64, (2021/08/14)

A compound of formula (I) and related aspects.

CYCLOBUTANE DERIVATIVES AS MODULATORS OF VOLTAGE-GATED POTASSIUM CHANNELS

-

Page/Page column 112, (2018/02/28)

The present invention provides compounds of the formula (I) and their use as Kv3 modulators.

Structure-based design of agents targeting the bacterial ribosome

Bower, Justin,Drysdale, Martin,Hebdon, Richard,Jordan, Allan,Lentzen, Georg,Matassova, Natalia,Murchie, Alastair,Powles, Jenifer,Roughley, Stephen

, p. 2455 - 2458 (2007/10/03)

Rational structure-based drug design has been applied to the antibiotic thiostrepton, in an attempt to overcome some of its' limitations. The identification of a proposed binding fragment allowed construction of a number of key fragments, which were derivatised to generate a library of potential antibiotics. These were then evaluated to determine their ability to bind to the L11 binding domain of the prokaryotic ribosome and inhibit bacterial protein translation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 148528-89-6